Eton Pharmaceuticals, Inc. (NASDAQ:ETON) Q4 2025 Earnings Call Transcript March 19, 2026 Eton Pharmaceuticals, Inc. misses on earnings expectations. Reported EPS is $0.05 EPS, expectations were ...
As you have seen, it has been a very active time at Eton. During the call, we will review fourth quarter results, provide additional color on the Hemangiol acquisition, and an update on our recent FDA ...
Jamie Price, the chief executive officer at Osaic, agrees that the tech upheaval is one of the biggest changes in the broker-dealer business. He waxes idealistic about third-party software demos he’s ...
Q4 2025 Earnings Call March 19, 2026 4:30 PM EDTCompany ParticipantsDavid Krempa - Chief Business OfficerSean Brynjelsen ...
Morning Overview on MSN
Prototype mass spectrometer analyzes up to 1B molecules at once
A reengineered mass spectrometer prototype can now analyze up to a billion molecules simultaneously, a leap from conventional instruments that handle only a few at a time. The advance, reported in ...
The 2026 Iran conflict caused Gulf airspace closures, exposing the risks of mega-hubs and the need for backup hubs like Sri ...
Strong caesium grades intersected in drill hole located outside the known mineralized zones at the CV13 Pegmatite, indicating ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results